Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo
Nature Chemical Biology2021Vol. 17(9), pp. 954–963
Citations Over TimeTop 10% of 2021 papers
Christian Dubiella, Benika J. Pinch, Kazuhiro Koikawa, Daniel Zaidman, Evon Poon, Theresa Manz, Behnam Nabet, Shuning He, Efrat Resnick, Adi Rogel, Ellen M. Langer, Colin J. Daniel, Hyuk‐Soo Seo, Ying Chen, Guillaume Adelmant, Shabnam Sharifzadeh, Scott B. Ficarro, Yann Jamin, Barbara Martins Da Costa, Mark W. Zimmerman, Xiaolan Lian, Shin Kibe, Shingo Kozono, Zainab M. Doctor, Christopher M. Browne, Annan Yang, Liat Stoler‐Barak, Richa B. Shah, Nicholas E. Vangos, Ezekiel A. Geffken, Roni Oren, Eriko Koide, Samuel Sidi, Ziv Shulman, Chu Wang, Jarrod A. Marto, Sirano Dhe‐Paganon, Thomas Look, Xiao Zhen Zhou, Kun Ping Lu, Rosalie C. Sears, Louis Chesler, Nathanael S. Gray, Nir London
Related Papers
- → The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease(2007)673 cited
- → Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins(2011)325 cited
- → The role of Pin1 in the development and treatment of cancer(2016)41 cited
- → KeePin’ the p53 Family in Good Shape(2004)27 cited
- Inhibition of peptidyl-prolyl isomerase (PIN1) and BRAF signaling to target melanoma.(2019)